Computed Tomography Perfusion of Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Initial Results

Objective To define the computed tomography (CT) perfusion characteristics of head and neck squamous cell carcinoma. Methods Fourteen consecutive patients with untreated squamous cell cancers of head and neck underwent CT of the head and neck along with CT perfusion imaging through the primary site. For the perfusion studies, CT density changes in blood and tissues were kinetically analyzed using the commercially available CT Perfusion 2 software (General Electric Medical Systems. Milwaukee, WI) on a GE Advantage Windows workstation. This yielded parameter maps of fractional tissue blood volume (mL/100 g), blood flow (mL · 100 g−1 · min−1), mean transit time (s), and microvascular permeability surface area product (mL · 100 g−1 · min−1). One head and neck radiologist analyzed perfusion data. Regions of interest (ROI) were placed over the primary tumor site, tongue base, and adjacent muscle groups. The average values of tissue blood volume (BV), blood flow (BF), mean transit time (MTT), and capillary permeability surface area product (CP) were then calculated for the tumor and compared with the average values for the tongue base and adjacent musculature. To determine a statistically significant difference between the tumor and muscle parameters, the Wilcoxon sign test, a nonparametric test for paired data, was employed. Results The average values of CP, BF, and BV were higher in primary tumor (41.9, 132.9, 6.2, respectively) than in tongue base or adjacent muscular structures. The MTT was reduced in primary tumors (4.0) compared with adjacent normal structures. The above differences were statistically significant (P < 0.05). Conclusions We obtained baseline perfusion data for head and neck squamous cell cancers and compared it with adjacent normal structures. Our initial results suggest that CT perfusion parameters (CP, BF, BV, and MTT) can be used to help differentiate head and neck squamous cell carcinoma (SCCA) from adjacent normal tissue.

[1]  W Van den Bogaert,et al.  Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  S. Brem,et al.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. , 1990, The American journal of pathology.

[3]  S. Howell,et al.  Rapid superselective high‐dose cisplatin infusion for advanced head and neck malignancies , 1992, Head & neck.

[4]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[5]  Ting-Yim Lee,et al.  Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases. , 2002, AJNR. American journal of neuroradiology.

[6]  J. Petrella,et al.  Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. , 2002, AJNR. American journal of neuroradiology.

[7]  P. V. van Rijk,et al.  Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Reto Meuli,et al.  CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. , 2002, Radiology.

[9]  W P Dillon,et al.  Multisection dynamic CT perfusion for acute cerebral ischemia: the "toggling-table" technique. , 2001, AJNR. American journal of neuroradiology.

[10]  R. Craen,et al.  Dynamic CT measurement of cerebral blood flow: a validation study. , 1999, AJNR. American journal of neuroradiology.

[11]  M. Lev,et al.  Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. , 2000, Seminars in ultrasound, CT, and MR.

[12]  R. Hayden,et al.  Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. , 1986, Radiology.

[13]  J. Thiran,et al.  Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. , 2001, AJNR. American journal of neuroradiology.

[14]  M. Lingen.  Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[15]  S. Merajver,et al.  Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  M. Remacle,et al.  Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient , 2000, The Laryngoscope.

[17]  R. Craen,et al.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.

[18]  S. Mukherji,et al.  Radiologic appearance of the irradiated larynx. Part II. Primary site response. , 1994, Radiology.

[19]  T. Murry,et al.  A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. , 1996, Archives of otolaryngology--head & neck surgery.

[20]  H. J. Arnold.  Introduction to the Practice of Statistics , 1990 .